Executive officer

Tamer Khayal, M.D.

Senior Vice President of International (former Chief Commercial Officer)·TransMedics Group, Inc.

About

Dr. Tamer Khayal served as TransMedics' Chief Commercial Officer from January 2018 until February 2026, when he transitioned to Senior Vice President of International.

He previously served as the company's Chief Medical Officer and Vice President of Clinical Development from 2006 to 2017 and as Director of Clinical Development from 2001 to 2006.

Prior to joining TransMedics he served for six years as Director of Clinical Affairs for Zentiva Group, a.s., a pharmaceutical company, leading clinical research, regulatory filings and clinical sales training for its Middle East and Africa operations, and was earlier a practicing physician; he holds an M.D. from Cairo University School of Medicine.

Since January 2018
Age 50
Tenure 8 yrs

Also at TransMedics Group, Inc.

WM Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director JT James R. Tobin Director; Chairperson of the Board EB Edward M. Basile Director; Chairperson of the Nominating and Corporate Governance Committee TG Thomas J. Gunderson Director; Chairperson of the Compensation Committee EJ Edwin M. Kania, Jr. Director SL Stephanie Lovell Director

Roles

Organization Role Dates Details
TransMedics Group, Inc. Senior Vice President of International (former Chief Commercial Officer) January 2018–present Current role
TransMedics Chief Medical Officer and Vice President of Clinical Development 2006-2017
TransMedics Director of Clinical Development 2001-2006
Zentiva Group, a.s. Director of Clinical Affairs Served for six years; led clinical research, regulatory filings and clinical sales training for Middle East and Africa operations.

Related

Company TransMedics Group, Inc. Company hub Person Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director Person James R. Tobin Director; Chairperson of the Board Person Edward M. Basile Director; Chairperson of the Nominating and Corporate Governance Committee Person Thomas J. Gunderson Director; Chairperson of the Compensation Committee Person Edwin M. Kania, Jr. Director Person Stephanie Lovell Director Person Merilee Raines Director; Chairperson of the Audit Committee Person David Weill, M.D. Director Person Gerardo Hernandez Chief Financial Officer and Treasurer Person Giovanni Cecere Chief Commercial Officer Person Nicholas Corcoran Senior Vice President of Supply Chain and Operations Person Matthew Forsyth Senior Vice President, General Counsel and Corporate Secretary
Source: TransMedics Group, Inc. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo